Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience

Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy

(2014) Jeremie Leporrier et al.   JOURNAL OF CLINICAL VIROLOGY

Metabolism, Excretion, and Mass Balance of the HIV-1 Integrase Inhibitor Dolutegravir in Humans

(2013) Stephen Castellino et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment

(2013) Stephen Weller et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

(2013) Pedro Cahn et al.   LANCET

Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial

(2013) François Raffi et al.   LANCET INFECTIOUS DISEASES

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection

(2012) David Boutolleau et al.   JOURNAL OF CLINICAL VIROLOGY

Safety and Efficacy of Dolutegravir in Treatment-Experienced Subjects With Raltegravir-Resistant HIV Type 1 Infection: 24-Week Results of the VIKING Study

(2012) Joseph J. Eron et al.   JOURNAL OF INFECTIOUS DISEASES

Dynamics of Raltegravir Resistance Profile in an HIV Type 2-Infected Patient

(2009) Li Xu et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity

(2009) María Salgado et al.   JOURNAL OF CLINICAL VIROLOGY

Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure

(2009) Sophie Stegmann et al.   JOURNAL OF CLINICAL VIROLOGY

Raltegravir treatment response in an HIV-2 infected patient: a case report

(2008) Nigel Garrett et al.   AIDS

Foscarnet salvage therapy efficacy is associated with the presence of thymidine-associated mutations (TAMs) in HIV-infected patients

(2008) Charlotte Charpentier et al.   JOURNAL OF CLINICAL VIROLOGY